Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline to improve lymphedema due to podoconiosis
ISRCTN11881662Phase 2Completed
- Sponsor
- University of Buea
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in podoconiosis comparing Doxycycline with Placebo control (2 arms). Primary endpoints: Lack of progression of podoconiosis lymphedema at 24 months and Long-term adherence to lymphedema self-care practices. Started May 2019; status: completed.
02
Drugs
doxycycline
03
Conditions
podoconiosis
Beyond the preview
Go deeper on ISRCTN11881662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11881662.